MeiraGTx Holdings plc (MGTX) stock
MGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/3065% below fair value
$8.46−0.28 (-3.20%)
Close on Nov 17, 2026Market cap $812.52MP/E 11.9Yield –
MeiraGTx profit margin
Profit margin (net margin) is net income as a percentage of revenue.
MeiraGTx's profit margin for the twelve months ending Jun 30, 2026 was 19.9%. For fiscal 2025 it was -140.3%, against -444.1% the year before. The highest annual figure on record is -140.3% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -140.3% | +303.8 |
| FY2024 | Dec 31, 2024 | -444.1% | +155.4 |
| FY2023 | Dec 31, 2023 | -599.5% | +214.7 |
| FY2022 | Dec 31, 2022 | -814.2% | −603.1 |
| FY2021 | Dec 31, 2021 | -211.0% | +161.6 |
| FY2020 | Dec 31, 2020 | -372.6% | +39.2 |
| FY2019 | Dec 31, 2019 | -411.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 50.0% | +1101.1 |
| Q1 FY2026 | Mar 31, 2026 | -15806.5% | −13730.6 |
| Q4 FY2025 | Dec 31, 2025 | 20.0% | +204.2 |
| Q3 FY2025 | Sep 30, 2025 | -12320.2% | −11959.7 |
| Q2 FY2025 | Jun 30, 2025 | -1051.1% | +16190.1 |
| Q1 FY2025 | Mar 31, 2025 | -2075.9% | +857.0 |
| Q4 FY2024 | Dec 31, 2024 | -184.2% | −1175.1 |
| Q3 FY2024 | Sep 30, 2024 | -360.5% | +507.6 |
| Q2 FY2024 | Jun 30, 2024 | -17241.1% | −16405.5 |
| Q1 FY2024 | Mar 31, 2024 | -2932.9% | −2022.1 |
| Q4 FY2023 | Dec 31, 2023 | 990.9% | +1765.1 |
| Q3 FY2023 | Sep 30, 2023 | -868.1% | −552.3 |
| Q2 FY2023 | Jun 30, 2023 | -835.6% | −284.5 |
| Q1 FY2023 | Mar 31, 2023 | -910.7% | −863.6 |
| Q3 FY2022 | Sep 30, 2022 | -774.2% | −400.8 |
| Q2 FY2022 | Jun 30, 2022 | -315.8% | +76.8 |
| Q1 FY2022 | Mar 31, 2022 | -551.1% | −37.1 |
| Q4 FY2021 | Dec 31, 2021 | -47.1% | +229.1 |
| Q3 FY2021 | Sep 30, 2021 | -373.4% | −247.1 |
| Q2 FY2021 | Jun 30, 2021 | -392.6% | +634.8 |
| Q1 FY2021 | Mar 31, 2021 | -514.0% | −141.5 |
| Q4 FY2020 | Dec 31, 2020 | -276.2% | −197.2 |
| Q3 FY2020 | Sep 30, 2020 | -126.3% | +165.7 |
| Q2 FY2020 | Jun 30, 2020 | -1027.4% | +23.3 |
| Q1 FY2020 | Mar 31, 2020 | -372.5% | +1918.3 |
| Q4 FY2019 | Dec 31, 2019 | -78.9% | – |
| Q3 FY2019 | Sep 30, 2019 | -292.0% | – |
| Q2 FY2019 | Jun 30, 2019 | -1050.7% | – |
| Q1 FY2019 | Mar 31, 2019 | -2290.8% | – |
See a number that looks wrong?